There’s a structural mismatch in how the public learns things. Marketing departments work in weeks; clinical trials work in years. By the time a careful study reaches publication, peer review, replication, and meta-analysis, the marketing version of the conclusion has already been on television for half a decade. The marketing version is also more confident, simpler, and sometimes contradicted by the eventual science. This isn’t a fringe complaint — it’s the dynamic behind decades of dietary advice, supplement booms, skincare claims, and “wellness” categories that keep delivering products before the evidence is in.
You can’t outrun this gap, but you can read around it once you know it exists.
Why the timing is rigged
A new product launch needs claims now, not in 2032. Marketing teams reach for whatever evidence they have — preliminary studies, in vitro results, mechanism-based reasoning, cherry-picked endpoints — and translate it into the most user-friendly version that legal will allow. Real science, meanwhile, is iterative. A first study suggests an effect; subsequent studies revise it; meta-analyses pool everything; consensus emerges over years. By the time the consensus arrives, the original product line has either been replaced (if the consensus is unfavorable) or continues unchanged with claims based on the discarded version of the science. The whole industry runs on the front of the curve where evidence is thin and excitement is high; the corrections get filed in journals nobody reads.
Pattern recognition for skeptical consumers
A few signals consistently indicate that marketing has run ahead of science. Watch for “studies show” without specific citations. Mechanism-based claims (“supports cellular health”) that don’t promise outcomes. Endpoints that are biomarkers rather than outcomes (HDL changes versus actual cardiovascular events; tumor shrinkage versus survival). Single-study findings that haven’t been replicated, especially from small samples or industry-funded trials. Claims that age-out — antioxidants supplements, omega-3s for general heart health, multivitamins for healthy adults all had glory periods that quietly faded as bigger trials reported negative or null results. None of these patterns prove a product is fake, but together they should slow your wallet down.
What survives the gap
A small set of interventions consistently outlast their marketing cycles because the underlying evidence keeps strengthening rather than dissipating. Vaccines for the diseases they target. Statins for high-risk cardiovascular patients. Smoking cessation. Resistance training for older adults. Mediterranean-style eating patterns. Sleep. These don’t get reinvented every five years because they don’t need to be — the trials keep replicating. When evaluating any new health or nutrition claim, ask whether it sits in this category or whether it’s a fresh launch trading on enthusiasm. The unsexy interventions that have been “old news” for decades are usually the safer bet, both medically and financially.
The takeaway
Marketing reaches conclusions faster than science can confirm or refute them, and the gap is where most consumer disappointment lives. Default to evidence that has aged well, demand specific citations rather than vague phrasing, and treat any claim too new to have been replicated as provisional. The science will catch up — usually a few years after the ad campaign.
Leave a Reply